Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Bemis Provides Update on Status of Pending Alcan Packaging Food Americas Acquisition

Bemis Company, Inc. today announced that it is involved in discussions with the staff of the Department of Justice regarding their review, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, of Bemis' pending acquisition of the Food Americas operations of Alcan Packaging, a business unit of international mining group Rio Tinto plc (LON: RIO; ASX: RIO).

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

These discussions include remedies which management believes would resolve the concerns expressed by the Department of Justice about the transaction.

Bemis previously indicated that it had anticipated receiving regulatory approval of the transaction by the end of 2009. While discussions are progressing, management no longer anticipates that approval will be received by December 31, 2009. It is now management's expectation that regulatory approval will be received in early 2010.

Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered "forward-looking" and are presented pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such content is subject to certain risks and uncertainties, including but not limited to the risk that further discussions will not resolve areas of dispute between the Department of Justice and the parties to the transaction; unexpected costs associated with completing the acquisition; and the availability and related cost of financing from banks and capital markets. Actual future results and trends may differ materially from historical results or those projected in any such forward-looking statements depending on a variety of factors which are detailed in the Company's regular SEC filings including the most recently filed Form 10-K for the year ended December 31, 2008.

Further information concerning some of the factors that could cause materially different results is included in the Company's reports on forms 10-K, 10-Q and 8-K filed with the Securities and Exchange Commission. Such reports are available from the Securities and Exchange Commission's public reference facilities and its Web site, Bemis' investor relations department, and Bemis' Web site.
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences